Pharmaceuticals

Retinal Disorder Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the retinal disorder treatment market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Retinal Disorder Treatment Market in 2026, and what figure is it projected to hit by 2030?

The retinal disorder treatment market has experienced robust growth in recent years. It is projected to increase from $13.69 billion in 2025 to $14.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be attributed to factors such as the rising prevalence of age-related macular degeneration, a globally increasing diabetic population, the proliferation of ophthalmology clinics and specialty hospitals, advancements in retinal imaging technologies, and improved awareness of retinal diseases.

The retinal disorder treatment market size is projected to experience robust expansion over the next few years, reaching $21.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth is influenced by the advancement of long-acting retinal drugs, the increasing approval of novel biologics and gene therapies, expanding access to eye care in emerging markets, rising investment in ophthalmic research, and a growing demand for personalized retinal treatments. Significant trends during this forecast period include the increasing adoption of anti-VEGF therapies, a shift towards minimally invasive retinal procedures, a greater preference for sustained-release drug formulations, the expansion of combination therapy approaches, and the rising use of home-based vision monitoring tools.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp

Which Drivers Are Affecting Market Participation In The Retinal Disorder Treatment Market?

The projected increase in diabetes cases is set to propel the expansion of the retinal disorder treatment market. Diabetes, a chronic health condition, is characterized by elevated blood glucose levels due to the body’s inadequate insulin production or inefficient use of the insulin it generates. Diabetic retinopathy stands as the most frequently occurring retinal disorder among individuals with diabetes. This condition arises from damage to the retina’s blood vessels, potentially leading to hemorrhaging, fluid seepage, and the formation of new blood vessels. Treatment for retinal disorders typically employs lasers to seal compromised blood vessels or eliminate abnormal ones. For illustration, in June 2024, data from the National Health Service, a UK-based government department, indicated that in 2023, the NHS identified an additional over half a million (549,000) individuals in England at risk of developing type 2 diabetes. This pushed the overall count of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, marking a significant rise from 3,065,825 in 2022. Consequently, the growing incidence of diabetes is a key driver for the retinal disorder treatment market’s growth.

What Segment Classifications Make Up The Retinal Disorder Treatment Market?

The retinal disorder treatment market covered in this report is segmented –

1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types

2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration

2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy

3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders

What Trends Are Driving The Growth Trajectory Of The Retinal Disorder Treatment Market?

Leading companies active in the retinal disorder treatment market are innovating new products, such as treatments for geographic atrophy, to serve wider customer bases, enhance sales, and boost revenue. Therapies for geographic atrophy primarily concentrate on managing symptoms, decelerating disease advancement, and supporting individuals in coping with visual impairment. For instance, in August 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for IZERVAY. IZERVAY, a novel complement C5 inhibitor, is notable as the sole approved treatment for geographic atrophy (GA) that demonstrated a statistically significant reduction (p<0.01) in the rate of GA progression at the 12-month primary endpoint in two Phase 3 clinical trials. This unique attribute confirms IZERVAY (avacincaptad pegol intravitreal solution) as an indicated and effective therapy for GA secondary to age-related macular degeneration (AMD).

Which Leading Companies Dominate The Retinal Disorder Treatment Market Share?

Major companies operating in the retinal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

How Does The Retinal Disorder Treatment Market Perform Across Major Global Regions?

North America was the largest region in the retinal disorder treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Retinal Disorder Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12701&type=smp

Browse Through More Reports Similar to the Global Retinal Disorder Treatment Market 2026, By The Business Research Company

Retinal Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Optic Nerve Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Retinal Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795